Nu Skin Enterprises, Inc. (NUS) Holdings Trimmed by Acrospire Investment Management LLC

Acrospire Investment Management LLC trimmed its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 57.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,055 shares of the company’s stock after selling 2,800 shares during the quarter. Acrospire Investment Management LLC’s holdings in Nu Skin Enterprises were worth $129,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Nu Skin Enterprises by 0.4% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 7,249 shares of the company’s stock valued at $456,000 after purchasing an additional 31 shares during the last quarter. US Bancorp DE boosted its holdings in Nu Skin Enterprises by 3.3% in the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after purchasing an additional 65 shares during the last quarter. Loudon Investment Management LLC boosted its holdings in Nu Skin Enterprises by 1.2% in the 2nd quarter. Loudon Investment Management LLC now owns 8,675 shares of the company’s stock valued at $545,000 after purchasing an additional 100 shares during the last quarter. Suntrust Banks Inc. boosted its holdings in Nu Skin Enterprises by 1.3% in the 1st quarter. Suntrust Banks Inc. now owns 8,117 shares of the company’s stock valued at $450,000 after purchasing an additional 102 shares during the last quarter. Finally, Capstone Asset Management Co. boosted its holdings in Nu Skin Enterprises by 2.3% in the 2nd quarter. Capstone Asset Management Co. now owns 4,989 shares of the company’s stock valued at $314,000 after purchasing an additional 110 shares during the last quarter. Institutional investors own 79.25% of the company’s stock.

Shares of Nu Skin Enterprises, Inc. (NUS) opened at 61.83 on Wednesday. The stock has a 50 day moving average of $60.27 and a 200-day moving average of $58.09. Nu Skin Enterprises, Inc. has a 1-year low of $46.35 and a 1-year high of $66.04. The stock has a market capitalization of $3.27 billion, a P/E ratio of 20.68 and a beta of 1.37.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The business had revenue of $550.10 million for the quarter, compared to analysts’ expectations of $548.09 million. During the same period last year, the company earned $0.79 earnings per share. The company’s quarterly revenue was down 8.4% on a year-over-year basis. Equities research analysts predict that Nu Skin Enterprises, Inc. will post $3.23 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 13th. Investors of record on Friday, August 25th were given a $0.36 dividend. The ex-dividend date was Wednesday, August 23rd. This represents a $1.44 annualized dividend and a dividend yield of 2.32%. Nu Skin Enterprises’s dividend payout ratio is presently 48.81%.

In related news, Director Daniel W. Campbell sold 4,607 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $62.48, for a total value of $287,845.36. Following the sale, the director now directly owns 63,753 shares of the company’s stock, valued at $3,983,287.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel D Matthew Dorny sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, July 5th. The stock was sold at an average price of $62.92, for a total transaction of $519,090.00. Following the completion of the sale, the general counsel now directly owns 46,730 shares in the company, valued at $2,940,251.60. The disclosure for this sale can be found here. Insiders sold 28,357 shares of company stock worth $1,783,535 over the last three months. Corporate insiders own 5.20% of the company’s stock.

NUS has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Wednesday, July 5th. BidaskClub lowered shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Deutsche Bank AG boosted their target price on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Bank of America Corporation boosted their target price on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a report on Monday, July 10th. Finally, Pivotal Research reiterated a “buy” rating and issued a $80.00 target price (up from $65.00) on shares of Nu Skin Enterprises in a report on Thursday, June 22nd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. Nu Skin Enterprises has a consensus rating of “Hold” and a consensus price target of $62.88.

COPYRIGHT VIOLATION WARNING: “Nu Skin Enterprises, Inc. (NUS) Holdings Trimmed by Acrospire Investment Management LLC” was first published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://transcriptdaily.com/2017/09/20/nu-skin-enterprises-inc-nus-holdings-trimmed-by-acrospire-investment-management-llc.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply